BioCentury
ARTICLE | Company News

Court temporarily halts Massachusetts Zohydro ban

April 15, 2014 11:30 PM UTC

A judge in the U.S. District Court for the District of Massachusetts granted a preliminary injunction stopping Massachusetts' statewide ban on pain drug Zohydro ER hydrocodone bitartrate from Zogenix Inc. (NASDAQ:ZGNX). Last month, Massachusetts authorities prohibited the prescription or sale of Zohydro ER until FDA approves an abuse deterrent formulation after Gov. Deval Patrick declared opiate addiction a public health emergency. Zogenix filed suit challenging Patrick's executive order (see BioCentury Extra, April 7).

Zogenix said the preliminary injunction becomes effective on April 22, after which Zohydro ER will be available in Massachusetts while the suit is ongoing. The product is an oral, non-abuse deterrent extended-release (ER) formulation of hydrocodone. There are no scheduled upcoming hearings listed on the docket for the suit. ...